Patients With Primary Biliary Cholangitis(PBC)

计划入组 30 人 · 首次发布于 2026 年 6 月 5 日

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

计划入组 117 人 · 首次发布于 2024 年 4 月 15 日

Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)

计划入组 100 人 · 首次发布于 2020 年 8 月 17 日

Primary sclerosing cholangitis(Engitix )

NOX inhibitors (primary biliary cholangitis/head and neck cancer)

Golexanolone

C₂₁H₃₁NO₂

Neopenda, PBC

United States

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

GSK's Linerixibat Shows Positive Phase III Results for Cholestatic Pruritus in Primary Biliary Cholangitis

Gilead's Seladelpar Receives European Commission Approval for Primary Biliary Cholangitis

EMA Endorses Tharimmune's TH104 Clinical Program for Chronic Pruritus in Primary Biliary Cholangitis